Business Context and Reporting Period
Company: Insulet Corporation
Filing Type: Form 8-K (Current Report)
Date of Report: February 5, 2013
Subject: Non-reliance on previously issued financial statements and announcement of a restatement.
Management and the Audit Committee concluded that the Company's audited consolidated financial statements for the year ended December 31, 2011, and unaudited quarterly periods from June 30, 2011, through September 30, 2012, must be restated. The restatement stems from accounting errors related to the June 2011 acquisition of Neighborhood Diabetes and the modification of convertible debt in the same period.
Key Financial Metrics and Restatement Impact
The filing details specific adjustments to balance sheet and income statement line items. The restatement primarily affects deferred tax assets, goodwill, and net loss for 2011 periods, with no impact on 2012 net loss.
Impact on 2011 Periods (Income Statement)
The restatement recognizes an income tax benefit of approximately $11.3 million that was previously incorrectly adjusted against goodwill. This results in a significant reduction of the reported net loss for 2011.
| Period | Net Loss (As Previously Reported) | Net Loss (As Restated) | Net Loss Per Share (Restated) |
|---|---|---|---|
| Three Months Ended June 30, 2011 | $(19,423) thousand | $(8,084) thousand | $(0.17) |
| Six Months Ended June 30, 2011 | $(29,269) thousand | $(17,930) thousand | $(0.39) |
| Nine Months Ended Sept 30, 2011 | $(42,831) thousand | $(31,492) thousand | $(0.68) |
| Year Ended Dec 31, 2011 | $(57,170) thousand | $(45,831) thousand | $(0.98) |
Impact on Balance Sheet (Selected Periods)
Adjustments include increases to goodwill and deferred tax assets, and increases to deferred tax liabilities.
| Line Item | Dec 31, 2011 (As Reported) | Dec 31, 2011 (As Restated) | Sept 30, 2012 (As Reported) | Sept 30, 2012 (As Restated) |
|---|---|---|---|---|
| Goodwill | $26,647 thousand | $37,536 thousand | $26,647 thousand | $37,536 thousand |
| Total Assets | $209,583 thousand | $221,322 thousand | $191,642 thousand | $203,381 thousand |
| Total Stockholders' Equity | $71,396 thousand | $82,735 thousand | $39,113 thousand | $50,452 thousand |
Material Changes Versus Prior Periods
- 2011 Net Loss Reduction: The restatement reduces the net loss for the full year 2011 by approximately $11.3 million due to the reclassification of a valuation allowance reduction as an income tax benefit.
- 2012 No Income Statement Impact: The restatement is not expected to affect the net loss for any period in 2012. However, balance sheet items (Goodwill, Deferred Tax Assets/Liabilities) are adjusted for 2012 quarters.
- Goodwill Adjustment: Goodwill increases by approximately $11.3 million for 2011 periods and $10.9 million for 2012 periods.
Guidance, Outlook, and Risks
Management Commentary: The errors were identified following a review of the June 2011 acquisition of Neighborhood Diabetes and the modification of convertible debt. The Company determined that $11.3 million in valuation allowance reduction should have been an income tax benefit, not a goodwill adjustment. Additionally, a $5.5 million deferred tax liability related to debt modification was identified, which offset the valuation allowance and had no effect on operations.
Future Filings: The Company plans to file amended Annual Reports (Form 10-K/A) and Quarterly Reports (Form 10-Q/A) on or before February 28, 2013 (Note: Text states 2012, but context implies 2013 given the filing date).
Risks and Contingencies: The filing explicitly states that previously issued financial statements for the affected periods should no longer be relied upon. The Company is correcting balance sheet presentations regarding deferred tax assets and liabilities.
Important Facts for Investor Verification
- Restatement Scope: Verify the amended 10-K/A and 10-Q/A filings expected by late February 2013 for corrected financial data.
- 2011 Profitability: Confirm the restated net loss of $(45.8) million for 2011 versus the previously reported $(57.2) million.
- Balance Sheet Strength: Note the increase in Total Stockholders' Equity for 2011 and 2012 periods due to the reclassification of tax benefits.
- No 2012 Earnings Impact: Verify that 2012 operating results (Net Loss) remain unchanged despite balance sheet adjustments.
- Acquisition Accounting: Review the specific accounting treatment for the Neighborhood Diabetes acquisition and convertible debt modification in the amended reports.